Reversible hypopigmentation with pazopanib

Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.

Saved in:
Bibliographic Details
Main Authors: B J Srinivasa, Bhanu Prakash Lalkota, Pramod S Chindar, Radheshyam Naik
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=4;spage=519;epage=520;aulast=Srinivasa
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.
ISSN:0971-5851